Les meilleurs doctors en Israël pour votre Radiothérapie pour les sarcomes - TOP 4 des médecins

Le Prof. Merimsky dirige l'Unité d'Oncologie des Tissus Mous et Osseux au Centre Médical Sourasky – un pionnier dans le traitement du sarcome avec plus de 25 ans d'expertise ciblée.

• Formation par un fellowship à l'Institut Gustave Roussy à Paris – le centre de référence européen pour le sarcome
• Membre de la faculté de l'ESMO pour le sarcome – contribue à l'élaboration des lignes directrices internationales de traitement
• A publié de manière approfondie sur les thérapies et les résultats des sarcomes
• Combine la radio-oncologie avec des approches de traitement systémique

Le Dr Dror Levin est spécialisé dans le traitement des sarcomes pédiatriques au Centre médical Sourasky – l'un des principaux hôpitaux israéliens pour les cancers de l'enfant.

• Directeur de l'hémato-oncologie pédiatrique à Sourasky
• Formé à l'Institut orthopédique Rizzoli – un leader mondial dans la prise en charge des sarcomes
• Coordonne le traitement des sarcomes avec les équipes d'oncologie orthopédique
• Membre de l'association israélienne d'hémato-oncologie pédiatrique (ISPHO)

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.